EP1685151A4 - Regeneration neuronale de peptides et methodes d'utilisation dans le traitement des troubles cerebraux - Google Patents
Regeneration neuronale de peptides et methodes d'utilisation dans le traitement des troubles cerebrauxInfo
- Publication number
- EP1685151A4 EP1685151A4 EP04800514A EP04800514A EP1685151A4 EP 1685151 A4 EP1685151 A4 EP 1685151A4 EP 04800514 A EP04800514 A EP 04800514A EP 04800514 A EP04800514 A EP 04800514A EP 1685151 A4 EP1685151 A4 EP 1685151A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- methods
- brain damage
- neural regeneration
- regeneration peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000006931 brain damage Effects 0.000 title 1
- 231100000874 brain damage Toxicity 0.000 title 1
- 208000029028 brain injury Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000001537 neural effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000008929 regeneration Effects 0.000 title 1
- 238000011069 regeneration method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Addiction (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51601803P | 2003-10-31 | 2003-10-31 | |
US58504104P | 2004-07-02 | 2004-07-02 | |
US61627104P | 2004-10-05 | 2004-10-05 | |
PCT/US2004/036203 WO2005042561A2 (fr) | 2003-10-31 | 2004-11-01 | Regeneration neuronale de peptides et methodes d'utilisation dans le traitement des troubles cerebraux |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1685151A2 EP1685151A2 (fr) | 2006-08-02 |
EP1685151A4 true EP1685151A4 (fr) | 2009-04-22 |
Family
ID=34557374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04800514A Withdrawn EP1685151A4 (fr) | 2003-10-31 | 2004-11-01 | Regeneration neuronale de peptides et methodes d'utilisation dans le traitement des troubles cerebraux |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1685151A4 (fr) |
JP (1) | JP5026083B2 (fr) |
WO (1) | WO2005042561A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1888635B1 (fr) * | 2005-05-06 | 2015-07-22 | Curonz Holdings Company Limited | Peptides de regénération neurale (nrp) et procédés pour les utiliser |
WO2007011595A2 (fr) * | 2005-07-15 | 2007-01-25 | Neuren Pharmaceuticals Limited | Peptides de regeneration neurale et antioxydants protegeant les neurones de la degenerescence |
CN101300031A (zh) * | 2005-10-31 | 2008-11-05 | 雪兰诺实验室有限公司 | 用sdf-1治疗和/或预防神经疾病 |
DK2212349T3 (da) * | 2007-10-17 | 2013-11-04 | Curonz Holdings Company Ltd | Syntetiske analoger af nerveregenationspeptider |
WO2013112002A1 (fr) * | 2012-01-27 | 2013-08-01 | 의료법인 성광의료재단 | Biomarqueur destiné à réduire ou soulager des symptômes de lésion cérébrale |
WO2014017927A1 (fr) * | 2012-07-27 | 2014-01-30 | Curonz Holdings Company Limited | Procédé de traitement d'une lésion du nerf optique, d'une ischémie ophtalmique ou d'une lésion de reperfusion ophtalmique |
EP2964332A4 (fr) * | 2013-03-08 | 2016-09-14 | Curonz Holdings Company Ltd | Peptides de régénération neurale et leurs utilisations |
MX2016004660A (es) * | 2013-10-11 | 2016-11-14 | Tarix Pharmaceuticals Ltd | Composiciones de peptido novedosas. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003018754A2 (fr) * | 2001-08-24 | 2003-03-06 | Neuronz Limited | Peptides de regeneration neurale et procedes d'utilisation de ces derniers dans le traitement des lesions cerebrales |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995006662A1 (fr) * | 1993-09-01 | 1995-03-09 | Start Technology Partnership | Facteur regulateur de neurones servant a promouvoir la survie des neurones |
-
2004
- 2004-11-01 EP EP04800514A patent/EP1685151A4/fr not_active Withdrawn
- 2004-11-01 JP JP2006538375A patent/JP5026083B2/ja not_active Expired - Fee Related
- 2004-11-01 WO PCT/US2004/036203 patent/WO2005042561A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003018754A2 (fr) * | 2001-08-24 | 2003-03-06 | Neuronz Limited | Peptides de regeneration neurale et procedes d'utilisation de ces derniers dans le traitement des lesions cerebrales |
Also Published As
Publication number | Publication date |
---|---|
WO2005042561A3 (fr) | 2006-10-12 |
WO2005042561A2 (fr) | 2005-05-12 |
JP5026083B2 (ja) | 2012-09-12 |
EP1685151A2 (fr) | 2006-08-02 |
JP2007511210A (ja) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1641522A4 (fr) | Procedes gastro-intestinaux et appareil d'utilisation de ces procedes dans le traitement de troubles | |
AU2003286611A8 (en) | Cytomodulating peptides and methods for treating neurological disorders | |
EP1641378A4 (fr) | Methodes et dispositifs de traitement de lesions cutanees | |
EP1640035A4 (fr) | Appareil de traitement cardiaque et procede de traitement cardiaque | |
GB2398810B (en) | Well treatment method and system | |
EP1680166A4 (fr) | Procedes et appareil pour traiter une insuffisance cardiaque | |
EP1928466A4 (fr) | Methode de traitement anti-cellulite par tpd et applications cosmetiques | |
EP1701664A4 (fr) | Systeme et procede de traitement d'un tissu | |
IL174918A0 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
IL174185A0 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
EP1662993A4 (fr) | Methodes et appareil de bioimpedance | |
EP1761204A4 (fr) | Dispositif implantable pour le traitement de maladies et procedes d'utilisation | |
GB2397528B (en) | Method and device for treatment of skin conditions | |
AU2003287909A8 (en) | Electro-therapeutic device and method of electro-therapeutic treatment | |
AU2002335657A8 (en) | Neural regeneration peptide and methods for their use in treatment of brain damage | |
PL378465A1 (pl) | Sposób i urządzenie do terapii leczniczej | |
EP1685151A4 (fr) | Regeneration neuronale de peptides et methodes d'utilisation dans le traitement des troubles cerebraux | |
EP1718360A4 (fr) | Procede et systeme de traitement cutane/capillaire | |
EP1606418A4 (fr) | Methodes de diagnostic et de traitement de l'epilepsie | |
EP1575993A4 (fr) | Methodes de traitement de patients et d'identification de therapeutique | |
GB2431578B (en) | Apparatus and method for use in the treatment of hair | |
EP1542654A4 (fr) | Traitement du photovieillissement et de la deterioration actinique de la peau | |
GB0410999D0 (en) | Method and aparatus for electrode dressing | |
GB2404864B (en) | Apparatus and method for stimulation of the human body | |
GB2406865B (en) | Well treatment system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060526 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL HR LT LV MK YU |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07K 1/00 20060101ALI20061125BHEP Ipc: A01N 37/18 20060101ALI20061125BHEP Ipc: A01N 61/00 20060101AFI20061125BHEP |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NEUREN PHARMACEUTICALS LIMITED |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090319 |
|
17Q | First examination report despatched |
Effective date: 20100121 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20121030 |